Jade House Recovery

Jade House Recovery

COO STARTER PACK

Welcome to
Jade House

Version 0.9 — February 2026 (Pre-Lease Execution)

Brian — Your line about the "two parts of the treatment business" stuck with me: do the treatment right, and build the business to keep the doors open.

This starter pack shows exactly how Jade House is building that second part — launch status, DCF/REMS dependencies, unit economics, RCM guardrails, and the patient portal prototype. It is designed to skim in minutes, with every claim tied back to the financial model and licensed industry research.

— John

01

Section One

Origin & Model

Origin — community and care

Jade House is designed as a rapid-access outpatient psychiatric + addiction clinic focused on:

Medication-Assisted Treatment (injectables + med management)

Interventional psychiatry (Spravato, TMS)

Evidence-based psychotherapy

Structured outpatient detox

Clean RCM + documentation discipline from day one

Speed to intake + compliance discipline + clean claims = durable margin.

02

Section Two

Launch Status

Launch Status — critical path

Facility Control

West Palm Beach — LOI submitted; lease in negotiation.

5,600 SF · Parking appears strong (600–1,000)

Target: Execute lease + proof of control → unlock DCF site steps

509 US-1, LAKE PARKSECOND CHOICE

Strong access + timeline; maintained as backup until lease executed.

927 BELVEDERE RD

Phased activation optionality.

Watch-outs: life safety/egress constraints for phased occupancy; humidity/mold risk if mothballed.

469 SPENCER DR

Potential speed advantage if zoning/use classification + parking interpretation are clean.

📋

Controlled-Document Note: Current policy manual address fields are placeholders. Upon executed lease, we will trigger a single controlled-document update (policy manual + evacuation routes + signage + DCF packet + payer enrollment profiles). No licensure or DEA documentation will rely on placeholder addresses.

Licensure + Compliance

DCF licensure sequencing mapped

Spravato REMS workflow built into clinical model

Documentation completion SLA: 24–48 hours

Authorization + front-end eligibility controls embedded in intake workflow

LAUNCH GATING ITEMS

1.

Executed lease

2.

Final floorplan approval

3.

Proof of control submission to DCF

4.

Final vendor install scheduling

03

Section Three

Capital & Runway

Capital & Runway

This section is intentionally concise: runway, burn, capital sources, and the cash-conversion assumptions that must be true for collections to start.

Capital Stack

$350K SBA (in process)

$350K invested

$50K additional private commitment secured

Additional lender conversations active

Month 9

Break-even target

55–60

Active patients at break-even

Cash Discipline

Front-end auth required before service

Documentation completion within 48 hours

Weekly denial review cadence

DSO monitored against 45-day base / 60-day stress scenario

NOTATION

Industry benchmarks are cited where applicable. All other figures are financial model assumptions (Feb 2026) and will be re-baselined after payer contracting + first 60 days of live claims.

04

Section Four

Service Mix

Year 1 Service Mix (Financial Model, Feb 2026):

MAT Injectables (Sublocade + Vivitrol)

~$1.53MPrimary revenue driver

Interventional Psychiatry (Spravato + TMS)

~$365K~20% of mix

Therapy (individual + group)

~$160K

Psychiatric E/M (eval + med management)

~$115K

UDS + ancillary services

~$20K

SCALE STRATEGY

Scale interventional services only after REMS execution + RCM SLA stability are demonstrated.

⚙️

Operational Reality: Spravato requires REMS-compliant monitoring + clean documentation + prior authorization discipline. Throughput is constrained by operations, not demand.

05

Section Five

Operating System

Intake → Treatment → Documentation → Claim

Access Discipline

Same-day callback standard

72-hour intake target

No-show salvage protocol

Documentation Discipline

24–48 hour completion SLA

Modifier-25 applied correctly when E/M is billed with injection

Injection inventory reconciliation weekly

RCM Guardrails

Eligibility verified before service

Authorization logged before scheduling

Denial root-cause tracking weekly

Target denial rate: ≤10%

Target A/R days: <30

06

Section Six

Authority Matrix

Clear ownership. No ambiguity.

Facility + Build-Out + Vendor Mgmt

Owner: COO

Escalation: CEO

Hiring + Staffing + HR

Owner: COO

Escalation: CEO

Clinical hiring authority: Medical Director. Recruiting pipeline support: Rhian Sharp.

Technology + App + Kipu Integration

Owner: COO (implementation + adoption)

Escalation: CEO (product direction + budget)

Referral Partnerships + BD

Owner: COO

Escalation: CEO

CEO for top-tier relationships.

Capital + Investor Relations

Owner: CEO

Escalation:

07

Section Seven

Patient Portal Prototype

Patient Portal — interactive prototype

12-screen interactive portal:

Admission workflow

Consents

Mood tracking (Kipu outcomes sync)

Messaging

Medication tracking

Scheduling

SOS

Goals

Referrals

Preview

The patient portal is not marketing — it is an operational extension of documentation, engagement, and retention discipline.

08

Section Eight

The Bottom Line

Jade House is not betting on a single procedure.

It is building a compliance-tight, documentation-disciplined, specialty-driven outpatient engine.

The treatment must work.

The business must stay open.

This portal shows how both are being built — in parallel.

Jade House Recovery

Jade House Recovery

John Visciano, Founder & CEO

[email protected]

917-960-1508

Prepared February 2026 — Confidential